Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/25 16:25 | 2/19/25 | ALXO | Health | Drug | Pharmaceutical Preparations | Pinto Shelly | CA | O | Interim | 8 | S | -88 | 7.14 | 0 | -12 | 94 | D | |||||||||||||||
2/21/25 16:23 | 2/19/25 | ALXO | Health | Drug | Pharmaceutical Preparations | Pons Jaume | CA | O | P,CSO | 10 | S.d | -1,772 | 10.94 | 0 | -162 | 628 | D | |||||||||||||||
2/21/25 16:20 | 2/19/25 | ALXO | Health | Drug | Pharmaceutical Preparations | Lettmann Jason | CA | DO | CEO | 1 | S | -2 | 1.15 | 0 | -2 | 170 | D | |||||||||||||||
8/16/24 17:09 | 8/14/24 | ALXO | Health | Drug | Pharmaceutical Preparations | Randolph Sophia | CA | O | CHIEF ME | 4 | S | -261 | 13.20 | 0 | -20 | 330 | D | |||||||||||||||
1/3/24 16:20 | 12/29/23 | ALXO | Health | Drug | Pharmaceutical Preparations | Garcia Peter S | CA | O | CFO | 1 | S | -28 | 15.04 | 0 | -2 | 85 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |